Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Mycosis Fungoides
Remco van Doorn, C.W. van Haselen, Pieter C. van Voorst Vader, et al.
Archives of Dermatology (2000) Vol. 136, Iss. 4
Closed Access | Times Cited: 357

Showing 1-25 of 357 citing articles:

WHO-EORTC classification for cutaneous lymphomas
Rein Willemze, Elaine S. Jaffe, Günter Burg, et al.
Blood (2005) Vol. 105, Iss. 10, pp. 3768-3785
Open Access | Times Cited: 3652
Survival Outcomes and Prognostic Factors in Mycosis Fungoides/Sézary Syndrome: Validation of the Revised International Society for Cutaneous Lymphomas/European Organisation for Research and Treatment of Cancer Staging Proposal
Nita Agar, Emma Wedgeworth, Siobhan Crichton, et al.
Journal of Clinical Oncology (2010) Vol. 28, Iss. 31, pp. 4730-4739
Closed Access | Times Cited: 757
Primary and secondary cutaneous CD30+lymphoproliferative disorders: a report from the Dutch Cutaneous Lymphoma Group on the long-term follow-up data of 219 patients and guidelines for diagnosis and treatment
Marcel W. Bekkenk, Françoise A. M. J. Geelen, Pieter C. van Voorst Vader, et al.
Blood (2000) Vol. 95, Iss. 12, pp. 3653-3661
Closed Access | Times Cited: 748
Long-term Outcome of 525 Patients With Mycosis Fungoides and Sézary Syndrome
Youn H. Kim, Howard L. Liu, Serena Mraz‐Gernhard, et al.
Archives of Dermatology (2003) Vol. 139, Iss. 7
Closed Access | Times Cited: 637
Phase 2 and 3 clinical trial of oral bexarotene (Targretin capsules) for the treatment of refractory or persistent early-stage cutaneous T-cell lymphoma.
Madeleine Duvic, Ángel G. Martín, Y. Kim, et al.
PubMed (2001) Vol. 137, Iss. 5, pp. 581-93
Closed Access | Times Cited: 424
EORTC consensus recommendations for the treatment of mycosis fungoides/Sézary syndrome
Franz Trautinger, Robert Knobler, Rein Willemze, et al.
European Journal of Cancer (2006) Vol. 42, Iss. 8, pp. 1014-1030
Closed Access | Times Cited: 408
Cutaneous Lymphoma International Consortium Study of Outcome in Advanced Stages of Mycosis Fungoides and Sézary Syndrome: Effect of Specific Prognostic Markers on Survival and Development of a Prognostic Model
Julia Scarisbrick, H. Miles Prince, Maarten H. Vermeer, et al.
Journal of Clinical Oncology (2015) Vol. 33, Iss. 32, pp. 3766-3773
Open Access | Times Cited: 364
Long-term Outcomes of 1,263 Patients with Mycosis Fungoides and Sézary Syndrome from 1982 to 2009
Rakhshandra Talpur, Lotika Singh, Seema Daulat, et al.
Clinical Cancer Research (2012) Vol. 18, Iss. 18, pp. 5051-5060
Open Access | Times Cited: 266
How I treat mycosis fungoides and Sézary syndrome
Sean Whittaker, Richard T. Hoppe, H. Miles Prince
Blood (2016) Vol. 127, Iss. 25, pp. 3142-3153
Open Access | Times Cited: 229
TCR sequencing facilitates diagnosis and identifies mature T cells as the cell of origin in CTCL
Ilan R. Kirsch, Rei Watanabe, John T. O’Malley, et al.
Science Translational Medicine (2015) Vol. 7, Iss. 308
Open Access | Times Cited: 197
The PROCLIPI international registry of early‐stage mycosis fungoides identifies substantial diagnostic delay in most patients
Julia Scarisbrick, Pietro Quaglino, H. Miles Prince, et al.
British Journal of Dermatology (2018) Vol. 181, Iss. 2, pp. 350-357
Open Access | Times Cited: 186
Follicular Mycosis Fungoides, a Distinct Disease Entity With or Without Associated Follicular Mucinosis
Remco van Doorn, E. Scheffer, Rein Willemze
Archives of Dermatology (2002) Vol. 138, Iss. 2
Open Access | Times Cited: 326
Clinicopathological spectrum of mycosis fungoides
Dmitry V. Kazakov, Günter Burg, Werner Kempf
Journal of the European Academy of Dermatology and Venereology (2004) Vol. 18, Iss. 4, pp. 397-415
Closed Access | Times Cited: 256
Joint British Association of Dermatologists and U.K. Cutaneous Lymphoma Group guidelines for the management of primary cutaneous T-cell lymphomas
Sean Whittaker, Jerry Marsden, M.F. Spittle, et al.
British Journal of Dermatology (2003) Vol. 149, Iss. 6, pp. 1095-1107
Open Access | Times Cited: 237
Multicenter study of pegylated liposomal doxorubicin in patients with cutaneous T‐cell lymphoma
Uwe Wollina, Reinhard Dummer, Norbert H. Brockmeyer, et al.
Cancer (2003) Vol. 98, Iss. 5, pp. 993-1001
Closed Access | Times Cited: 217
Oncogenomic analysis of mycosis fungoides reveals major differences with Sézary syndrome
Remco van Doorn, Marloes S. van Kester, Remco Dijkman, et al.
Blood (2008) Vol. 113, Iss. 1, pp. 127-136
Open Access | Times Cited: 208
Clinical efficacy of zanolimumab (HuMax-CD4): two phase 2 studies in refractory cutaneous T-cell lymphoma
Youn H. Kim, Madeleine Duvic, Erik Obitz, et al.
Blood (2007) Vol. 109, Iss. 11, pp. 4655-4662
Open Access | Times Cited: 208
Prognostic factors in transformed mycosis fungoides: a retrospective analysis of 100 cases
Marchina F. Benner, Patty M. Jansen, Maarten H. Vermeer, et al.
Blood (2011) Vol. 119, Iss. 7, pp. 1643-1649
Open Access | Times Cited: 202
Long-term outcomes of patients with advanced-stage cutaneous T-cell lymphoma and large cell transformation
Suzanne O. Arulogun, H. Miles Prince, Jonathan Ng, et al.
Blood (2008) Vol. 112, Iss. 8, pp. 3082-3087
Open Access | Times Cited: 186
Overview of Lymphoma Diagnosis and Management
Matthew J. Matasar, Andrew D. Zelenetz
Radiologic Clinics of North America (2008) Vol. 46, Iss. 2, pp. 175-198
Closed Access | Times Cited: 174
Clinical Staging and Prognostic Factors in Folliculotropic Mycosis Fungoides
Suzanne van Santen, R.E.J. Roach, Remco van Doorn, et al.
JAMA Dermatology (2016) Vol. 152, Iss. 9, pp. 992-992
Open Access | Times Cited: 146
Evolving Insights in the Pathogenesis and Therapy of Cutaneous T‐cell lymphoma (Mycosis Fungoides and Sezary Syndrome)
Henry K. Wong, Anjali Mishra, Timothy S. Hake, et al.
British Journal of Haematology (2011) Vol. 155, Iss. 2, pp. 150-166
Open Access | Times Cited: 144
Cutaneous T‐cell lymphoma: 2017 update on diagnosis, risk‐stratification, and management
Ryan A. Wilcox
American Journal of Hematology (2017) Vol. 92, Iss. 10, pp. 1085-1102
Open Access | Times Cited: 141
Cutaneous T‐cell lymphoma: 2016 update on diagnosis, risk‐stratification, and management
Ryan A. Wilcox
American Journal of Hematology (2015) Vol. 91, Iss. 1, pp. 151-165
Open Access | Times Cited: 139
Prognostic factors, prognostic indices and staging in mycosis fungoides and Sézary syndrome: where are we now?
Julia Scarisbrick, Y.H. Kim, Sean Whittaker, et al.
British Journal of Dermatology (2014) Vol. 170, Iss. 6, pp. 1226-1236
Closed Access | Times Cited: 138
Page 1 - Next Page

Scroll to top